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Abstract 
 
Background: Garcinia xanthochymus extract has been reported to have several pharmacological properties. This study 
was conducted to evaluate cytotoxic and anti-inflammatory activities of G. xanthochymus extracts on cell lines. 
Methods: The roots and stem barks of plant were extracted using maceration method with n-hexane, dichloromethane 
and methanol, successively. Cytotoxic activity of the extracts was tested against MCF-7 breast adenocarcinoma using 
MTT assay. Anti-inflammatory study was evaluated using RAW 264.7 mouse macrophage cells. The nitric oxide 
production in LPS-stimulated cells was measured using Griess reagent. Results: The results of cytotoxic and anti-
inflammatory study showed that dichloromethane and n-hexane extracts of root and stem bark exhibited cytotoxic 
activity in dose-dependent manner. Meanwhile, for anti-inflammatory study, all root extracts together with stem bark 
dichloromethane and n-hexane extracts reduce NO production in LPS-stimulated cells in dose dependent manner. 
Conclusions: This finding indicated that G. xanthochymus extracts might become interesting candidate for treatment of 
cancer and inflammation. 
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Introduction 
 
Cancer is a major global burden and according to World 
Health Organization (WHO), 14.1 million new cases of 
cancer reported worldwide and 8.2 million people died 
due to cancer in 2012. Cancer is defined as the 
uncontrolled division of abnormal cells and able to 
invade other tissues. It may occur when a cell starts 
ignoring the instruction of the cell cycle checkpoint 
mechanism. This mechanism controls the rate of cell 
proliferation and as it is failed, cell eventually starts to 
divide in an uncontrolled manner.1 Major concern 
involves the sharp rise in breast cancer cases since it is 
the most leading cause of cancer death and frequently 
diagnosed cancer among women in 140 out of 184 
countries worldwide.2 Increment in burden brings about 
concern to find new therapy against cancer which is cost 
effective with fewer side effects. Meanwhile, inflammation 
is the defensive response of the body which is non-
specific towards the tissue damage. There are many 
conditions that could trigger inflammation such as 
pathogens, abrasions, chemical irritation, distortion or 
disturbances of cells and extreme temperature. A normal 
inflammation response should be short-lived which 
means it is self-limited by the down-regulations of pro-
inflammatory proteins and up-regulations of anti-
inflammatory proteins.3 Even though it is a good host 
defensive response, prolonged inflammation can result 
in various physiological dysfunctions.4 This undesirable 
condition leads to impairment of regular physiology and 
development of inflammatory diseases such as rheumatic 
arthritis, multiple sclerosis, inflammatory bowel disease 
and gastritis.5,6 
 
The utilization of natural sources to search for new 
pharmacologically active agent has led to the discovery 
of many clinically beneficial drugs that contributes to a 
vital role in the treatment of human disease. Up till 
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today, natural product continues to play essential roles 
in healthcare. In 1985, the WHO estimated that 
approximately 65% of the world population depends on 
plant-derived traditional medicine for their primary 
health care meanwhile in remaining population of 
developed countries, plant products still play indirect 
role in the healthcare system.7 Garcinia species is 
common in Southeast Asia. This species is rich source 
of phytochemicals that include xanthones, flavonoids, and 
phenolic acids.8 Other than that, plant species originated 
from this genus are famously known for its medicinal 
values of antiprotozoal, antibacterial, anti-inflammatory, 
anti-immunosuppressive, anti-fungal, and anti-oxidative.9 
G. xanthochymus was commonly used by old folk 
medicine for bilious condition, diarrhea, and dysentery.10 
In vitro investigation reported antioxidant activity and 
cytotoxic activity against SW-480 colon cancer cells of 
benzophenones from the fruit of G. xanthochymus.11 
Other antioxidant activity also shown by leaf, root and 
fruits extracts from G. xanthochymus.10 Therefore, it can 
be concluded that plant of this species have good 
antioxidant properties and this present study was 
conducted to investigate the ability of G. xanthochymus 
root and stem bark extracts in cytotoxicity and anti-
inflammatory activities towards selected cell lines  
 
Methods 
 
Plant material and crude extract preparation. The G. 
xanthochymus root and stem bark (3.465 kg and 702.5 
g) were obtained on 28th August 2013 from West 
Sumatera, Indonesia. Plant species was identified by Dr 
Shamsul Khamis from University Putra Malaysia and 
voucher specimen (PIIUM 0222) was deposited at 
herbarium of Kulliyyah of Pharmacy, International 
Islamic University Malaysia. 
 
Dried and powdered root and stem bark macerated with 
n-hexane, DCM and MeOH successively for 3 times for 
3 days each. The extracts were then filtered and 
evaporated to dryness at 50 °C using rotary evaporator 
to yield concentrated crude extract. Total yield (w/w) 
for root extracts were 0.34% for n-hexane extract, 
0.23% for DCM extract and 4.96% for MeOH extract. 
Meanwhile, for stem bark extracts the total yield (w/w) 
were 0.21% for n-hexane extract, 0.92% for DCM 
extract and 4.54% for MeOH extract. 
 
Cytotoxic activity. Cytotoxic activity was carried out 
using MTT assay as previously described12 with 
modification on MCF-7 breast adenocarcinorma cells. 
MCF-7 cell was obtained from the courtesy of Prof. 
Masa-Aki Ikeda of Tokyo Medical and Dental 
University, Tokyo, Japan. Cells were grown in complete 
medium (DMEM with 10% foetal bovine serum and 1% 
penicillin-streptomycin) at 37  °C with 5% of CO2. 
MCF-7 cells were seeded in 96-well plate at density of 
2.0×105 cells/mL. After reached confluence, cells were 
treated with samples (0-526 µg/mL) dissolved in 
ethanol for 24 hours. After treatment ended, cells were 
washed with phosphate buffer saline (PBS) twice and 20 
µL of MTT (Calbiochem, USA) solution (5 mg/mL) 
was added to each well and further incubated for 4 
hours. Then, 100 µL of DMSO (Fisher Chemical, 
Thermo Fisher Scientific, USA) was added and the 
microplate was left at room temperature for 1 hour. 
After 1 hour, the absorbance was measured using 
microplate reader at 570 nm wavelength and 630 nm 
reference wavelength. The IC50 was established by 
extrapolation from linear regression of the data from 
cell viability percentage. 
 
Anti-inflammatory activity. RAW 264.7 mouse 
macrophage cell was purchased from American Type 
Culture Collection (ATCC), Virginia, USA. RAW 264.7 
macrophage cells used in this anti-inflammatory study 
were less than 20 passages. Cells were seeded into 96-
well with density of 4.0-5.0×105 cells/mL and exposed 
with samples (0-100 µg/mL) for 24 hours at 37 °C with 
5% of CO2 atmosphere. After 24 hours, cell viability 
was assessed using MTT assay as described previously. 
 
Nitric oxide (NO) production. NO production 
determination was done as previously described13 with 
minor modification. RAW 264.7 macrophage cells were 
seeded into 24-well plate at density of 5.0-6.0×105 
cells/mL until it reached confluent. Cells were pre-
treated with or without samples (10-60 µg/mL) for 1 
hour and incubated with lipopolysaccharide (LPS) 
(Sigma-Aldrich Chemical Co., St. Louis, USA) at 
concentration of 1 µg/mL for 15 hours at 37 °C with 5% 
of CO2 atmosphere. Then, 50 µL of each medium 
supernatant was mixed with 50 µL Griess reagent (1:1) 
(Sigma-Aldrich Chemical Co., St. Louis, USA) and left 
at room temperature for 10 minutes. Absorbance was 
measured at 540 nm wavelength and values obtained 
were compared with the NaNO2 reference curve to 
determine the nitrite production. 
 
Statistical analysis. All qualitative data are representative 
of at least three independent experiments. Values are 
expressed as mean±SD. Statistical analyses were 
conducted using one-way Analysis of Variance (ANOVA). 
The statistical package IBM SPSS Statistics 21 for 
Windows was used in the analysis. 
 
Results 
 
The results for cytotoxic activity of stem bark and root 
extracts are shown in Figure 1 and Figure 2, respectively. 
 
The IC50 of the stem bark and root extracts are presented 
in Table 1. The stem bark and root extracts were also 
tested for their anti-inflammatory activity. The results 
for NO production inhibition are shown in Figure 3 and 
Figure 4. 
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Figure 1.  Effects of G. xanthochymus Stem Bark Extracts 
on MCF-7 Cell Viability. Error Bars Represent 
mean±SD of Cell Viability Percentage as 
Determined by Three Repeated Experiments. 
*p < 0.05 when Compared to the Untreated 
Control. a) Stem Bark DCM Extract; b) Stem 
Bark MeOH Extract; c) Stem Bark n-hexane 
Extract 
 
 
Discussion 
 
The extracts showed cytotoxic activity in dose-dependent 
manner. Significant difference was observed at selected 
treatment concentrations when compared with untreated 
control. Cell without any treatment exposure was the 
untreated control and based from result, it showed 
highest cell viability. According to US NCI plant 
screening program, crude extract is considered cytotoxic 
when IC50 is lower than 30 µg/mL.14 Since IC50 for 
DCM and n-hexane stem bark and root extracts obtained 
(Table 1) were more than 30 µg/mL, it can be concluded 
that DCM and n-hexane stem bark and root extracts pose 
 
Figure 2.  Effects of G. xanthochymus Root Extracts on 
MCF-7 Cell Viability. Error Bars Represent 
mean±SD of Cell Viability Percentage as 
Determined by Three Repeated Experiments.  
*p < 0.05 when Compared to the Untreated 
Control. a) Root DCM Extract; b) Root MeOH 
Extract; c) Root n-hexane Extract 
 
 
 
Table 1. IC50 of G. xanthochymus Extracts 
 
G. xanthochymus extracts IC50 (µg/mL) 
Cytotoxic 
activity 
Stem bark DCM 318.85 + 
Stem bark MeOH - - 
Stem bark n-hexane 293.51 + 
Root DCM 307.30 + 
Root MeOH - - 
Root n-hexane 388.88 + 
* 
* * 
* 
* 
* * * 
* 
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weak cytotoxic activity to be considered as potential 
anti-cancer agent. However, in terms of cytotoxicity 
against MCF-7 cells, IC50 for stem bark n-hexane extract 
was the lowest (293.51 µg/mL) as compared to the rest. 
Similiarly, previous investigation of Garcinia extracts 
of different species did exhibit selective cytotoxic 
activity on MCF-7 cell.15 
 
Another aspect needed to be considered that this present 
study is carried out based on crude DCM, MeOH and n-
hexane extracts. There is possibility of variety compounds 
exist in the plant extract and the mixture of compounds 
and impurities in extracts might hide the potential anti-
cancer activity. 
 
The investigation of drug interaction in multicompound 
remedies is difficult because of interaction among 
compound where some may show less specific activity 
and some may reduce the toxicity of more therapeutically 
effective plant.16 Thus, the effect of potential anti-cancer  
 
   
 
 
 
 
Figure 3.  Effects of G. xanthochymus Stem Barks Extracts on NO Production Inhibition. Error Bars Represent mean±SD of 
Nitrite Concentration as Determined by Triplicate of Single Experiment. *p < 0.05 when Compared to the Positive 
Control. a) Stem Bark DCM Extract; b) Stem Bark MeOH Extract; c) Stem Bark n-hexane Extract 
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compound can be fractionated and isolated from the 
crude extracts.  
 
In order to evaluate extracts effect on anti-inflammatory 
activity, extracts were tested against RAW 264.7 
macrophage cells. The cell viability assay was first done 
to determine suitable dose to be used for NO production 
test and possible cytotoxic effect of extracts on RAW 
264.7 cells. From the cell viability result, n-hexane stem 
bark and root extracts affect cell viability with IC50 of 
65.92 and 76.44 µg/mL respectively (data not shown). 
Hence, dose ranging from 10-60 µg/mL was chosen as 
dose for nitric oxide production test. The extracts effect 
on NO production inhibition was analysed using LPS-
stimulated RAW 264.7 cells. Cellular model of LPS 
stimulated macrophage is extensively used to measure 
anti-inflammatory activity.4 This study compares NO 
production of LPS-stimulated cell treated with extracts 
with positive control and negative control. Positive 
control used was cell exposed to LPS only. Since there 
is no treatment towards the cell, it was expected that the 
positive control produce the highest NO production.  
 
 
 
 
 
 
Figure 4.  Effects of G. xanthochymus Root Extracts on NO Production Inhibition. Error Bars Represent mean±SD of Nitrite 
Concentration as Determined by Triplicate of Single Experiment. *p < 0.05 when Compared to the Positive 
Control. a) Root DCM Extract; b) Root MeOH Extract; c) Root n-hexane Extract 
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Meanwhile, negative control of the study was untreated 
cell without LPS induction. Untreated cell was 
expected to produce lowest NO since there was no 
exposure to inflammatory stimulus. The extracts 
significantly reduce nitrite oxide production in LPS-
induced cells in dose-dependent manner except for 
stem bark MeOH extract since the extract did not shows 
significant decrease in NO level. Previous finding did 
also reported the NO reduction ability of different 
extract of Garcinia species on LPS and IFN-γ-induced 
RAW 264.7 cells.15 
 
In host defence against extracellular stimuli, macrophage 
plays vital role. It is the first cellular mediators of the 
innate immune response alongside with neutrophils and 
dendritic cells.17 One of the extracellular stimuli that 
could activate macrophage is LPS. Upon macrophage 
activation by LPS, the innate response of host immune 
response results in production of pro-inflammatory 
cytokines, nitric oxide (NO), and prostaglandin-E2 
(PGE2), which are the main cytotoxic and pro-apoptotic 
mechanisms participating in the innate response in 
many mammals.18-20 Inflammation initiated by LPS 
upregulates inducible nitric oxide synthase (iNOS) which 
later generates high NO.13 Owing to this, measurement 
of NO production is a method for evaluating the anti-
inflammatory effects of plant extracts.21 Exposure of LPS 
to RAW 264.7 macrophage cells upregulate iNOS and 
pre-treatment of cell with varying extracts concentration 
(10-60 µg/mL) prior to LPS induction was able to 
reduce the NO production. 
 
Other than that, it is interesting to observe the DCM 
and n-hexane extracts for their cytotoxicity and anti-
inflammatory pattern. Good cytotoxic and anti-
inflammatory activities are shown by DCM and n-
hexane extracts of stem bark and root. Hence, further 
analysis can be suggested for DCM and n-hexane extracts 
of stem bark and root since cancer and inflammation are 
related in way that the inflammation responses contribute 
role in tumour development.22 It is also interesting to 
suggest further study on DCM and n-hexane extract 
synergistic effect in reducing inflammation and killing 
cancer cell since such speculation can be made based 
on our present findings.  
 
Conclusions 
 
G. xanthochymus root and stem bark extracts showed 
dose-dependent cytotoxic activity towards MCF-7 cell 
line. The extracts were also able to inhibit NO production 
LPS-stimulated RAW 264.7 macrophage cells indicated 
its potential as a source for inflammation treatment. 
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